Table 5. Performance of Multimarker Panels in Non-NSCLC Conditions.
| Benign Lung | TB | Prostate Cancer | Breast Cancer | ||||
|---|---|---|---|---|---|---|---|
| Correctly Classified as Non-NSCLC (%)† | |||||||
| IGFBP-1 | Kal 10 | 58 | 50 | 88 | 64 | ||
| IGFBP-1 | Ferritin | 58 | 25 | 24 | 40 | ||
| IGFBP-1 | sIL-1Ra | 65 | 58 | 76 | 72 | ||
| IGFBP-1 | Ferritin | CEACAM-1 | 57 | 20 | 16 | 36 | |
| IGFBP-1 | sIL-1Ra | CEACAM-1 | 62 | 33 | 68 | 60 | |
| IGFBP-1 | Ferritin | sIL-1Ra | 57 | 25 | 28 | 44 | |
| IGFBP-1 | Ferritin | CEACAM-1 | ALCAM | 50 | 20 | 28 | 44 |
| IGFBP-1 | Ferritin | CEACAM-1 | HE4 | 49 | 20 | 16 | 16 |
†
Performance at 95% SP for NSCLC versus Healthy Controls;
TB – pulmonary tuberculosis